Product Information

DARIFENACIN ER 7.5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.5762 per EA under NDC 33342027607. Its NADAC has been published 441 times since Mar 14, 2018.

FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Darifenacin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for DARIFENACIN ER 7.5 MG TABLET has been published 441 times since Mar 14, 2018, and over the history we have for it it has declined 90.7%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.